Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in ...

The following conversation has been lightly edited for clarity and grammar. “We’ve shown GLP-1s lead to more diagnoses of thyroid cancer. But they don’t lead to more cases of thyroid cancer ...

A 2010 animal study found that long-term exposure to liraglutide, a GLP-1 receptor agonist, increased rodents’ risk of medullary thyroid cancer, the rarest form, making up 3% to 4% of all human ...

The HRs for thyroid cancer among SU and SGLT2i users were 1.32 and 1.16, respectively. In piecewise models, patients beginning GLP-1RA treatment had an HR of 1.75 and 3.30 compared to SU and ...

Of over 350,000 adults with type 2 diabetes, thyroid cancer risk was significantly higher within the first year after GLP-1 agonist initiation compared with SGLT2 inhibitors, DPP-4 inhibitors, or ...

The conversion from accelerated to traditional approval was based on evidence from the randomized, multicenter, open-label, phase 3 LIBRETTO-531 trial (ClinicalTrials.gov Identifier: NCT04211337 ...

The Food and Drug Administration (FDA) approved Retevmo (selpercatinib) for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer with a RET ...

RET fusions are found in about 10 percent of thyroid tumors that originate in follicular cells. This includes anaplastic thyroid cancer, the most aggressive and difficult-to-treat form of the disease.

Even when this cancer spreads to the lymph nodes, it responds well to treatment. Follicular and medullary thyroid cancers are less common than papillary cancer, but their prognosis is good overall.

There are different types of thyroid cancer. The number staging for medullary thyroid cancer is different to the staging system for other types of thyroid cancer. This page is about staging medullary ...

Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer. Journal of Nuclear Medicine, 2023; jnumed.123.266537 DOI ...

Guenther, T., et al. (2023). Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer.